Trial Details 1 Total Sites

Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

To determine if it is feasible to use neoadjuvant immunotherapy (or immunotherapy plus chemotherapy) to reduce treatment intensity and improve long-term quality of life while maintaining very high cure rates.

phase

Phase 2

status

Recruiting

enrollment

32

score

32

start date

2021-12-13

last updated

2022-01-10

Baltimore, Maryland
facility
Johns Hopkins University
1 facility
Recruiting